Lithethefatsi tsa hypoglycemic
| KATSE # | Lebitso la Sehlahiswa | Tlhaloso |
| CPD0004 | Ertugliflozin | Ertugliflozin, eo hape e tsejoang e le PF-04971729, ke inhibitor e matla le e khethang ea sodium e itšetlehileng ka glucose cotransporter 2 le moemeli oa bongaka bakeng sa kalafo ea mofuta oa 2 lefu la tsoekere. |
| CPDA0048 | Omarigliptin | Omarigliptin, e tsejoang hape e le MK-3102, ke inhibitor e matla le e nkang nako e telele ea DPP-4 bakeng sa kalafo ea hang ka beke ea lefu la tsoekere la mofuta oa 2. |
| CPDA1089 | Retagliptin | Retagliptin, eo hape e tsejoang e le SP-2086, ke DPP-4 inhibitor e ka sebelisoang ho phekola lefu la tsoekere la Mofuta oa 2. |
| CPDA0088 | Trelagliptin | Trelagliptin, eo hape e tsejoang e le SYR-472, ke inhibitor ea dipeptidyl peptidase-4 (DPP-4) e sebetsang nako e telele e ntseng e etsoa ke Takeda bakeng sa kalafo ea lefu la tsoekere la mofuta oa 2 (T2D). |
| CPDA2039 | Linagliptin | Linagliptin, eo hape e tsejoang e le BI-1356, ke inhibitor ea DPP-4 e ntlafalitsoeng ke Boehringer Ingelheim bakeng sa kalafo ea lefu la tsoekere la mofuta oa II. |
| CPDA0100 | Sitagliptin | Sitagliptin (INN; e neng e tsejoa pele e le MK-0431 mme e rekisoa ka lebitso la khoebo la Januvia) ke sethethefatsi sa molomo sa antihyperglycemic (anti-diabetic) sa sehlopha sa dipeptidyl peptidase-4 (DPP-4) inhibitor. |
| CPD0854 | LX-4211 | LX-4211 ke inhibitor e matla e habeli ea SGLT2/1; Lithethefatsi tsa Antidiabetes. |
| CPDA1553 | LX-2761 | LX2761 ke SGLT1 inhibitor e sebetsang sebakeng sa heno e matla haholo ka har'a vitro mme e liehisa ho monya ha tsoekere ka har'a vivo ho ntlafatsa taolo ea glycemic. |
